Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

ELTROMBOPAG OLAMINE vs ROMIPLOSTIM: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

ELTROMBOPAG OLAMINE vs ROMIPLOSTIM: Safety Overview

Metric ELTROMBOPAG OLAMINE ROMIPLOSTIM
Total FAERS Reports 16,074 7,510
Deaths Reported 3,457 865
Death Rate 21.5% 11.5%
Hospitalizations 3,284 1,812
Average Patient Age 56.5 yrs 56.7 yrs
% Female Patients 57.7% 55.7%
FDA Approval Date Apr 18, 2024 N/A
Manufacturer XLCare Pharmaceuticals Inc. Amgen, Inc
Route ORAL SUBCUTANEOUS
Marketing Status Prescription Prescription